2008 (EUR'000)
Sales and services
332,607
Gross margin
REBITDA (1)
REBIT (2)
Net profit (loss)
Equity
Net cash position
Current liabilities
Total assets
Return on equity
Return on capital employed (ROCE)
Share price at December 31 (Euro)
Number of shares
Market Capitalization
Earnings per share (EPS) - (Euro per share)
Enterprise value
EV/REBITDA
5,9
EMPLOYEES AT DECEMBER 31
(1) REBITDA: Recurring earnings before interest, taxes, depreciation, and amortization. (2) REBIT: Recurring earnings before interest and taxes.
IBA Press Releases
The Cyclone 11 at SNM'09
Read it in : english -
Data concerning transparency - Capital increase
Read it in : english - french - dutch -
IBA and BV Cyclotron VU extend partnership in PET tracers supply
Sales and operating results by business unit
Sales
Molecular Imaging
Proton Therapy
Dosimetry
Other Accelerators
Recurring operational profit/(loss)
Technology & Equipment
Sales trends
Sales by geographic sector
R&D 2008 .
Paul-Emmanuel Goethals
Director Corporate Business Development & Investor Relations
Chemin du Cyclotron, 3 1348 Louvain-la-Neuve, BELGIUM Tel: +32.10.47.58.16 paul-emmanuel.goethals@iba-group.com
